Reckitt Spared Fees In ‘Close Call’ After Losing Mucinex Suit

Reckitt Benckiser LLC won’t have to pay attorney fees racked up by generic-drug makers it unsuccessfully sued on claims that they ripped off patents for its Mucinex respiratory relief drug, although a New Jersey federal judge on Friday said the decision on the fees was a “close call”…

Read this piece in its entirety at Law360.

Comments

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s